Something to note: oral treatment & if successful:
https://www.google.com.au/amp/s/www.nytimes.com/2021/10/17/health/covid-treatment-access-molnupiravir.amp.html
3% vaccination rate across Africa, quoted in this article. That’s appalling. Oral treatments for COVID-19 should know no boundaries. They don’t need cold-chain nor expense or expertise to hospitals administering IV expensive MABS. Other Drug companies (ie Merck) will allow out-licensing with cheaper cost to Govts/patients for oral antivirals +/- WHO support.
https://www.reuters.com/business/healthcare-pharmaceuticals/aurobindo-pharma-stop-molnupiravir-trial-moderate-covid-19-patients-2021-10-08/
Interesting article above on Molnupiravir trials in India.
GLTAH![]()
- Forums
- ASX - By Stock
- DXB Chart
Something to note: oral treatment & if...
-
-
- There are more pages in this discussion • 880 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DXB (ASX) to my watchlist
|
|||||
Last
56.0¢ |
Change
-0.010(1.75%) |
Mkt cap ! $313.3M |
Open | High | Low | Value | Volume |
56.0¢ | 58.5¢ | 54.0¢ | $2.912M | 5.208M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 98950 | 56.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
56.5¢ | 75812 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 98971 | 0.560 |
2 | 116640 | 0.555 |
5 | 158817 | 0.550 |
6 | 305253 | 0.545 |
16 | 312040 | 0.540 |
Price($) | Vol. | No. |
---|---|---|
0.565 | 75812 | 8 |
0.570 | 142382 | 4 |
0.575 | 101800 | 3 |
0.580 | 12500 | 2 |
0.585 | 81479 | 7 |
Last trade - 15.31pm 19/06/2024 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |
The Watchlist
CC9
CHARIOT CORPORATION LTD
Shanthar Pathmanathan, MD
Shanthar Pathmanathan
MD
Previous Video
Next Video
SPONSORED BY The Market Online